CAPPARIELLO, ALFREDO
 Distribuzione geografica
Continente #
NA - Nord America 973
EU - Europa 487
AS - Asia 330
SA - Sud America 1
Totale 1.791
Nazione #
US - Stati Uniti d'America 971
IE - Irlanda 183
CN - Cina 119
SG - Singapore 90
DE - Germania 88
IT - Italia 61
HK - Hong Kong 58
TR - Turchia 52
UA - Ucraina 42
GB - Regno Unito 35
FI - Finlandia 28
FR - Francia 12
SE - Svezia 12
CZ - Repubblica Ceca 9
RU - Federazione Russa 9
VN - Vietnam 6
IN - India 3
BE - Belgio 2
NL - Olanda 2
CA - Canada 1
ES - Italia 1
GR - Grecia 1
IL - Israele 1
KZ - Kazakistan 1
LU - Lussemburgo 1
LV - Lettonia 1
PA - Panama 1
PE - Perù 1
Totale 1.791
Città #
Chandler 227
Dublin 182
Jacksonville 159
Boardman 76
Santa Clara 72
Singapore 71
Hong Kong 58
New York 48
Izmir 30
Lawrence 27
Nanjing 27
Princeton 27
San Mateo 25
Ashburn 21
Wilmington 21
Munich 19
Nanchang 17
L'aquila 16
Ann Arbor 13
Milan 12
Shanghai 11
Beijing 10
Dallas 10
Brno 9
Falls Church 9
Helsinki 9
Los Angeles 9
Bremen 8
Kitzingen 8
Berlin 7
Kunming 7
Dong Ket 6
Hebei 6
Mountain View 6
Rome 6
Seattle 6
Woodbridge 6
L’Aquila 5
Norwalk 5
Shenyang 5
Verona 4
Des Moines 3
Guangzhou 3
Hangzhou 3
Jiaxing 3
Jinan 3
Lappeenranta 3
Moscow 3
Tappahannock 3
Tianjin 3
Brussels 2
Cedar Knolls 2
Changsha 2
Dearborn 2
Francavilla Al Mare 2
Guiyang 2
London 2
Menlo Park 2
Philadelphia 2
Phoenix 2
Pune 2
Saint Petersburg 2
Amsterdam 1
Athens 1
Avon 1
Barnsley 1
Borås 1
Buffalo 1
Chicago 1
Deyang 1
Dongguan 1
Düsseldorf 1
Edinburgh 1
Eschborn 1
Fairfield 1
Frankfurt am Main 1
Fremont 1
Friesland 1
Fuzhou 1
Galliate 1
Genova 1
Haikou 1
Harbin 1
Hull 1
Istanbul 1
Lanzhou 1
Lima 1
Luxembourg 1
Manocalzati 1
Miami 1
Montazzoli 1
New Orleans 1
Nizhniy Novgorod 1
Omsk 1
Oral 1
Ottawa 1
Palagonia 1
Panama City 1
Piera 1
Qingdao 1
Totale 1.389
Nome #
Biotechnological approach for systemic delivery of membrane Receptor Activator of NF-κB Ligand (RANKL) active domain into the circulation 108
Osteoblast-Derived Extracellular Vesicles Are Biological Tools for the Delivery of Active Molecules to Bone 76
The Great Beauty of the osteoclast 75
An experimental therapy to improve skeletal growth and prevent bone loss in a mouse model overexpressing IL-6 73
The "soft" side of the bone: unveiling its endocrine functions. 71
Lipocalin 2: A New Mechanoresponding Gene Regulating Bone Homeostasis 71
A Combined Fc-OPG/hPTH(1-34) Therapy to Restore Impaired Skeletal Growth and Bone Loss in a Mouse Model of IL-6 Dependent Juvenile Inflammatory Diseases 66
Regulatory loops involving IGFBP5 account for a fine tuning regulation of osteoblast and osteoclast activity in the context of the IL-6 pathway 63
Committed Osteoclast Precursors Colonize the Bone and Improve the Phenotype of a Mouse Model of Autosomal Recessive Osteopetrosis 61
A new heterozygote mutation (R714C) of the osteopetrosis gene, pleckstrin homolog domain containing family M (with run domain) member 1 (PLEKHM1) impairs vescicular acidification and reduces tartrate-resistant acid phosphatase activity in osteoclasts 61
REGULATORY LOOPS INVOLVING IGFBP5 ACCOUNT FOR A FINE TUNING REGULATION OF OSTEOBLAST ACTIVITY 61
A new heterozygous mutation (R714C) of the osteopetrosis gene, Pleckstrin Homolog Domain Containing Family M (With Run Domain) Member 1 (PLEKHM1), impairs vesicular acidification and increases TRACP secretion in osteoclasts 60
Extracellular Vesicles From Osteotropic Breast Cancer Cells Affect Bone Resident Cells 59
Anti-osteoblastogenic, pro-inflammatory and pro-angiogenic effect of extracellular vesicles isolated from the human osteosarcoma cell line MNNG/HOS 57
Lipocalin 2 increases after high-intensity exercise in humans and influences muscle gene expression and differentiation in mice 55
Clinical, genetic and cellular analysis of forty-nine osteopetrotic patients: implications for diagnosis and treatment 54
Inoculation of osteoclast precursors improves the phenotype of osteopetrotic oc/oc mice 54
Tumour-derived extracellular vesicles (EVs): A dangerous “message in a bottle” for bone 54
Prolonged chronic consumption of a high fat with sucrose diet alters the morphology of the small intestine 54
Macrophage-derived extracellular vesicles as carriers of alarmins and their potential involvement in bone homeostasis 53
Inhibition of c-Src reduces IL-6 expression in vivo and in vitro 50
Notch2 pathway mediates breast cancer cellular dormancy and mobilisation in bone and contributes to haematopoietic stem cell mimicry 49
Genetics, pathogenesis and complications of osteopetrosis 47
Extracellular Vesicles and Resistance to Anticancer Drugs: A Tumor Skeleton Key for Unhinging Chemotherapies 46
Ferroptosis resistance cooperates with cellular senescence in the overt stage of nonalcoholic fatty liver disease/nonalcoholic steatohepatitis 46
New experimental therapy to rescue impaired skeletal growth and bone loss in a mouse model of IL-6 dependent juvenile inflammatory diseases 46
Extracellular Vesicles in Bone Tumors: How to Seed in the Surroundings Molecular Information for Malignant Transformation and Progression 45
The antiinflammatory and antifibrotic effect of olive phenols and Lactiplantibacillus plantarum IMC513 in dextran sodium sulfate–induced chronic colitis 43
Effects of osteoblast-derived extracellular vesicles on aggressiveness, redox status and mitochondrial bioenergetics of MNNG/HOS osteosarcoma cells 40
Reprint of: The Great Beauty of the osteoclast 39
PPAR-Gamma Orchestrates EMT, AGE, and Cellular Senescence Pathways in Colonic Epithelium and Restrains the Progression of IBDs 23
Circulating Extracellular Vesicles Express Receptor Activator of Nuclear Factor κB Ligand and Other Molecules Informative of the Bone Metabolic Status of Mouse Models of Experimentally Induced Osteoporosis 18
PPAR-Gamma coordinates EMT, AGE, and senescence signaling and mitigates the intestinal fibrosis in IBDs 15
Editorial: Extracellular vesicles as means of the activation, metabolic change induction, and remodeling of the tumor microenvironment 14
Antisteatotic and antifibrotic activity of a new synthetic GPR120 receptor agonist in mice overfed with a “Western-style diet” 12
G‑Protein-Coupled Receptor 120 Agonist Mitigates Steatotic and Fibrotic Features Triggered in Obese Mice by the Administration of a High-Fat and High-Carbohydrate Diet 9
Totale 1.828
Categoria #
all - tutte 9.598
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 9.598


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202080 0 0 0 0 0 0 32 0 21 5 1 21
2020/2021163 4 21 0 21 21 2 21 1 27 1 37 7
2021/2022122 3 10 4 1 6 5 2 10 26 3 11 41
2022/2023589 42 42 5 75 50 63 2 43 236 2 20 9
2023/2024211 14 8 14 19 19 69 2 2 4 7 5 48
2024/2025327 28 13 60 36 71 54 65 0 0 0 0 0
Totale 1.828